Written question asked by Julian Lewis (Conservative) on Friday, 20 June 2025, in the House of Commons. It was due for an answer on Wednesday, 25 June 2025 (named day). It was answered by Ashley Dalton (Labour) on Wednesday, 25 June 2025 on behalf of the Department of Health and Social Care.
Advanced Therapy Medicinal Products
- Question
-
To ask the Secretary of State for Health and Social Care, if he will designate a Minister in his Department to (a) have responsibility for the field of cell and gene therapies and (b) chair his Department's Advanced Therapies Medicinal Products Coordination Group.
- Answer
-
The Parliamentary Under-Secretary of State for Patient Safety, Women’s Health and Mental Health, Baroness Merron, is the Minister with responsibility for life sciences and innovation, and cell and gene therapies are included in this remit.
In September 2024, the Department stood up an advanced therapies co-ordination group which aims to create a joined-up ecosystem that will support the development, regulation, and delivery of advanced therapy medicinal products in the United Kingdom. This group is chaired at the Senior Civil Service Grade 1 level. We note the recent report from the Cell and Gene Collective, titled Tomorrow’s Science, Today’s NHS, including the ask for a Minister to chair the group, and we will consider the report’s recommendations in due course.
Secondary information
- Type
- Written question
- Reference
- 61481
- Session
- 2024-26
- Subjects
- Departmental responsibilities Advanced therapy medicinal products
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2025-09-05 23:28:00 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/61481
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/61481
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/61481